Skip to main content
. 2017 Aug 21;6(8):e006127. doi: 10.1161/JAHA.117.006127

Table 1.

Characteristics Across Quartiles of Direct Discharge Home Post‐TAVR

Direct Discharge Home % (Number of Hospitals) [Number of Patents] Overall (N=329) [18 568] Quartile 1 9.3% to 59.2% (N=82) [4473] Quartile 2 59.3% to 72.1% (N=81) [5435] Quartile 3 72.2% to 81.6% (N=84) [5011] Quartile 4 81.7% to 100.0% (N=82) [3649] P Valuea
Patient characteristics
Age (median, IQR) 84.0, 79.0 to 88.0 84.0, 79.0 to 88.0 84.0, 79.0 to 88.0 84.0, 78.0 to 88.0 83.0, 78.0 to 87.0 <0.001
Female sex, N (%) 9028 (48.6) 2317 (51.8) 2655 (48.9) 2429 (48.5) 1627 (44.6) <0.001
Nonwhite race, N (%) 865 (4.7) 158 (3.5) 239 (4.4) 211 (4.2) 257 (7.0) <0.001
Coronary disease, N (%) 10 684 (57.5) 2536 (56.7) 3112 (57.3) 2958 (59.0) 2078 (57.0) 0.129
Atrial fibrillation, N (%) 7762 (41.8) 1974 (44.1) 2298 (42.3) 2121 (42.3) 1369 (37.5) <0.001
Prior stroke, N (%) 2223 (12.0) 578 (12.9) 629 (11.6) 630 (12.6) 386 (10.6) 0.008
Diabetes mellitus, N (%) 6547 (35.3) 1498 (33.5) 1922 (35.4) 1824 (36.4) 1303 (35.7) 0.017
Peripheral arterial disease, N (%) 5672 (30.6) 1369 (30.6) 1718 (31.6) 1533 (30.6) 1052 (28.8) 0.094
Heart failure, N (%) 14 244 (76.7) 3500 (78.3) 4250 (78.2) 3732 (74.5) 2762 (75.7) <0.001
Chronic lung disease, N (%) 5050 (27.2) 1125 (25.2) 1545 (28.4) 1396 (27.9) 984 (27.0) 0.001
Home oxygen, N (%) 2365 (12.7) 546 (12.2) 673 (12.4) 697 (13.9) 449 (12.3) 0.045
Renal function, N (%) 0.150
GFR ≥30 16 837 (90.7) 4017 (89.8) 4933 (90.8) 4557 (90.9) 3330 (91.3)
GFR <30 996 (5.4) 248 (5.5) 311 (5.7) 264 (5.3) 173 (4.7)
On dialysis 689 (3.7) 187 (4.2) 185 (3.4) 177 (3.5) 140 (3.8)
STS predicted mortality rate (median, IQR) 6.8%, 4.5% to 10.2% 6.9%, 4.7% to 10.3% 7.0%, 4.7% to 10.6% 6.8%, 4.5% to 10.3% 6.3%, 4.2% to 9.4% <0.001
Treatment characteristics
LVEF (median, IQR) 57%, 45% to 63% 56%, 45% to 63% 58%, 45% to 65% 58%, 45% to 63% 56%, 48% to 63% 0.011
Femoral access, N (%) 12 473 (67.2) 2688 (60.1) 3468 (67.1) 3393 (67.7) 2744 (75.2) <0.001
General anesthesia, N (%) 17 461 (95.0) 4385 (98.0) 5104 (93.9) 4728 (94.4) 3424 (93.8) <0.001
Transfusion, N (%) 6300 (33.9) 1829 (40.9) 1941 (35.7) 1568 (31.3) 962 (26.4) <0.001
Vascular access complication, N (%) 953 (8.0) 220 (7.8) 279 (7.8) 240 (7.8) 214 (8.8) 0.491
In‐hospital stroke/TIA, N (%) 347 (1.9) 81 (1.8) 124 (2.3) 89 (1.8) 53 (1.5) 0.037
Cardiac arrest, N (%) 396 (2.1) 89 (2.0) 135 (2.5) 117 (2.3) 55 (1.5) 0.012
Aortic dissection, N (%) 38 (0.2) 10 (0.2) 12 (0.2) 8 (0.2) 8 (0.2) 0.873
Hours in ICU (median, IQR) 37.0, 24.0 to 70.9 47.7, 25.0 to 76.0 40.7, 24.2 to 72.0 40.0, 24.2 to 70.5 28.0, 23.3 to 49.9 <0.001
Hospital characteristics
Region, N (%) <0.001
Northeast 76 (23.1) 33 (40.2) 26 (32.1) 13 (15.5) 4 (4.9)
West 58 (17.6) 9 (11.0) 12 (14.8) 15 (17.9) 22 (26.8)
Midwest 78 (23.7) 25 (30.5) 16 (19.8) 21 (25.0) 16 (19.5)
South 117 (35.6) 15 (18.3) 27 (33.3) 35 (41.7) 40 (48.8)
Annual TAVR volume (median, IQR) 21.0, 14.0 to 30.0 20.0, 13.0 to 25.0 24.0, 16.0 to 35.0 22.0, 15.0 to 32.5 19.0, 13.0 to 29.0 0.052
Number of beds (median, IQR) 533.0, 383.0 to 695.0 542.5, 352.0 to 687.0 571.0, 409.0 to 729.0 526.5, 393.5 to 664.5 496.0, 371.0 to 700.0 0.518
Teaching hospital, N (%) 207 (62.9) 51 (62.2) 54 (66.7) 58 (69.1) 44 (53.7) 0.183

GFR indicates glomerular filtration rate; ICU, intensive care unit, IQR, interquartile range; LVEF, left ventricular ejection fraction; STS, Society of Thoracic Surgeons; TAVR, transcatheter aortic valve replacement; TIA, transient ischemic attack.

a

P value for comparison across hospital quartiles.